What bipolar costs, and who pays it
The paper’s headline is $202 billion a year. Only about $25 billion of it was measured in claims data; the rest, caregiving included, is modelled. Read the measured slice first.
The claim
“Caregiving is the biggest cost of bipolar disorder.”
Not shown The caregiving figure is the paper’s largest line, but it is modelled from a survey of caregivers, not measured.
- Study
- Cost-of-illness model
- Year
- 2015 costs, published 2018
- Peer review
- Yes
- Funding
- Otsuka and Lundbeck
Cloutier M, Greene M, Guerin A, Touya M, Wu E. The economic burden of bipolar I disorder in the United States in 2015. Journal of Affective Disorders 2018;226:45–51.Funded by Otsuka Pharmaceutical Development & Commercialization; two authors are employees of Otsuka and Lundbeck. Paired here with Bowden CL, Bipolar disorder and work loss, American Journal of Managed Care, for the employment side without the industry funding.
What kind of paper this is
A cost-of-illness model built on three US insurance claims databases for direct healthcare costs, the literature for the uninsured, and government and published figures for the rest, at an assumed bipolar I prevalence of 1%. Excess cost is the difference between what people with bipolar I incur and what matched people without it incur.
What it found
Total costs of $202.1 billion, or $81,559 per person; excess costs of $119.8 billion, or $48,333 per person. The excess breaks down as caregiving 36%, direct healthcare 21%, unemployment 20%. Sensitivity analyses put the excess between $101 and $124 billion. Bowden’s review adds the employment detail: six months after a manic hospitalisation, 43% of one cohort were employed, although 80% were symptom-free or mildly symptomatic.
Table view
| Category | Share |
|---|---|
| Caregiving | 36% |
| All other categories | 23% |
| Direct healthcare | 21% |
| Unemployment | 20% |
Table view
| Category | Share |
|---|---|
| Symptom-free or mild | 80% |
| Employed | 43% |
What it did not find
Most of the headline is modelled, not measured. The Second Read of this paper goes line by line: about $25 billion comes from claims data, $82 billion is a general-population baseline, and $95 billion is carried over from other studies, the caregiving estimate among them. So the caregiving share below is an input, not a finding. Direct healthcare costs count only diagnosed people, so the undiagnosed are missing. The 1% prevalence is an assumption, and the model is bipolar I only. The funding is pharmaceutical, which does not make the arithmetic wrong but does shape what gets counted as a cost worth reducing. The caregiving figure is still worth reading closely, because no drug company has a product for it; just read it as an estimate.
What you would change on Monday
Even modelled, the caregiving input says something you can act on: the unpaid labour of the person who watches you is real and large, and so is the job lost while symptom-free. So the Recovery Plan is not a courtesy to your partner; it addresses the line the paper estimates as largest. And the Work Protection Kit exists because being well is not the same as being employed.
Where it sits in the tools
Corrections
None. To challenge a claim, email [email protected] with the specific line.
One paper, read for what it can carry. Not clinical advice; the editorial policy and medical disclaimer apply.